CLINICAL_TRIALS
trial_result
· 2025-07-25
Clinical Trial Update: Study of Pembrolizumab and Radiotherapy in Liver Cancer [Phase 2]
Summary
Phase 2 study evaluating pembrolizumab with radiotherapy for hepatocellular carcinoma was terminated, with results posted on 2025-07-25.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University Health Network, Toronto | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: TERMINATED | Results posted: 2025-07-25